Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Mild cognitive impairment

Topic: Amyloid, tau and blood-test diagnosis

The aim of this study is to build and validate a model based on structural magnetic resonance imaging (sMRI) to predict the progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD). A total of 343 patients with MCI were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database as study subjects. Among them, 154 patients progressed to AD during the 48-month follow-up. All subjects were randomly divided into a training set (n = 240) and a validation set (n = 103) in a 7:3 ratio according to enrollment time. The baseline T1-weighted (T1W) structural MR images of each patient were automatically segmented into whole-brain three-dimensional (3D) white and gray matter images based on the training set data. In addition, radiomics signatures were extracted from each structural image. Baseline neuropsychological scores were combined with the radiomics signatures to construct a prediction model using machine learning. The diagnostic accuracy and reliability of the model were evaluated using the receiver operating characteristic (ROC) curve analysis in both the training and validation sets. Stepwise logistic regression analysis showed that clinical dementia rating (CDR), Alzheimer's Disease Assessment Scale (ADAS-cog) and radiomics markers were independent predictors of progression from MCI to AD. ROC curve showed that the AUC values of CDR, ADAS-cog and radiomics markers in the training set and validation set were 0.895 and 0.882, respectively. The sensitivity was 0.933 and 0.977, and the specificity was 0.669 and 0.661, respectively. DeLong test showed that the diagnostic efficacy of the comprehensive model was significantly different from that of the independent predictors (P = 0.023). The integrated model, based on structural analysis of magnetic resonance images, can accurately identify and predict individuals with MCI at high risk of progressing to AD.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Li, Y., Yi, P., Jin, M., Li, Y., & Chen, W. (2025). A radiomics model predicts progression from mild cognitive impairment to alzheimer’s disease using structural MRI. Scientific Reports. https://doi.org/10.1038/s41598-025-19586-3

Vancouver

Li Y, Yi P, Jin M, Li Y, Chen W. A radiomics model predicts progression from mild cognitive impairment to alzheimer’s disease using structural MRI. Scientific Reports. 2025. doi:10.1038/s41598-025-19586-3. PMID: 41083541.

BibTeX

@article{li2025-41083541,
  author  = {Li, Yifei and Yi, Pengcheng and Jin, Mingmin and Li, Yifan and Chen, Wei},
  title   = {{A radiomics model predicts progression from mild cognitive impairment to alzheimer’s disease using structural MRI}},
  journal = {Scientific Reports},
  year    = {2025},
  doi     = {10.1038/s41598-025-19586-3},
  pmid    = {41083541},
  url     = {https://doi.org/10.1038/s41598-025-19586-3}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

A model combining clinical dementia rating, Alzheimer's Disease Assessment Scale scores and radiomics markers from structural MRI predicted progression from mild cognitive impairment to Alzheimer's disease. It is a prediction model only and does not test any treatment, cure or prevention.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 43 of 100.43 of 100 points earned57 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific Reports)
Journal's citation record 3 / 4 Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 240 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Wei Chen: h-index 26 (OpenAlex, whole career)
Institution's track record 1 / 3 Zhejiang University: institution h-index 1,040 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41083541)
Free to read 2 / 2 Free to read
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Mild cognitive impairment

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →